Table 3.
Beck scale for suicidal ideation - mean ratings at baseline and 4 days
Day/group | Placebo (n=21) | 16 mg (n=20) | 32 mg (n=20) | F | df | Pa | ||
---|---|---|---|---|---|---|---|---|
Baselineb | 6.38±1.93 | 7.10±3.82 | 5.65±3.75 | 0.981 | 2 | 0.381 | ||
Day1b | 3.90±2.64 | 1.95±3.39 | 1.30±2.17 | 4.896 | 2 | 0.011 | ||
Day2b | 2.42±2.23 | 0.200±0.894 | 0.050±0.223 | 16.965 | 2 | 0.00 | ||
Day3b | 0.809±2.04 | 0.00±0.00 | 0.00±0.00 | 3.144 | 2 | 0.051 | ||
Day4b | 0.333±1.15 | 0.00±0.00 | 0.00±0.00 | 1.664 | 2 | 0.198 | ||
F | 69.073 | 48.004 | 36.713 | |||||
P | 0.00 | 0.00 | 0.00 | |||||
df | 4 | 4 | 4 | |||||
aThe three groups were compared by ANOVA, bNumbers shown are means±SD. SD: Standard deviation | ||||||||
Mean BSSIb | Mean±SD | Pa | ||||||
Placebo versus 16 mg | 0.921±0.455 | 0.116 | ||||||
Placebo versus 32 mg | 1.37±0.455 | 0.011 | ||||||
16 mg versus 32 mg | 0.450±0.461 | 0.595 |
aThe three groups were compared by post hoc t-tests, bNumbers shown are means±SD. SD: Standard deviation, BSSI: Beck scale for suicidal ideation